Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
02/19/1998 | WO1998006743A1 Acylated peptide cytolytic peptide inhibitors |
02/19/1998 | WO1998006742A2 Peptides for treatment of inflammation and shock |
02/19/1998 | WO1998006741A1 Thrombin inhibitors |
02/19/1998 | WO1998006740A1 Dipeptide benzamidine as a kininogenase inhibitor |
02/19/1998 | WO1998006734A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
02/19/1998 | WO1998006733A1 Nucleotide sequence encoding the cd33-like protein |
02/19/1998 | WO1998006441A1 USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE (mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
02/19/1998 | WO1998006440A2 Phenotypic conversion of cells mediated by external guide sequences |
02/19/1998 | WO1998006437A2 Compositions and methods for polynucleotide delivery |
02/19/1998 | WO1998006431A2 Method for treating diabetes |
02/19/1998 | WO1998006430A1 Vaccines, antibodies, proteins, glycoproteins, dnas and rnas for prophylaxis and treatment of cryptosporidium parvum infections |
02/19/1998 | WO1998006429A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
02/19/1998 | WO1998006426A1 Use of a plasminogen activator for the treatment of pulmonary disorders |
02/19/1998 | WO1998006425A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin |
02/19/1998 | WO1998006424A1 Cancerous metastasis inhibitors for oral administration |
02/19/1998 | WO1998006423A1 Composition comprising insulin and insulin-like growth factor-i (igf-i) |
02/19/1998 | WO1998006422A1 Hematopoietic stem cell proliferating agents |
02/19/1998 | WO1998006421A1 Therapeutic compositions for treatment of cancer |
02/19/1998 | WO1998006420A1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
02/19/1998 | WO1998006419A1 Enhancement of antimicrobial peptide activity by metal ions |
02/19/1998 | WO1998006418A1 Compositions of plant carbohydrates as dietary supplements |
02/19/1998 | WO1998006417A1 Methods to treat cerebral ischemic injury and other neuronal diseases |
02/19/1998 | WO1998006416A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
02/19/1998 | WO1998006415A2 Anti-chlamydial methods and materials |
02/19/1998 | WO1998006408A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
02/19/1998 | WO1998006389A1 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
02/19/1998 | WO1998006278A1 Methods and compositions for increasing the anaerobic working capacity in tissues |
02/19/1998 | WO1998006266A1 Antiviral materials |
02/19/1998 | WO1998006264A1 Plasmin-depletion therapy |
02/19/1998 | WO1998006248A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN |
02/19/1998 | WO1998001102A3 Treatment for itch of chicken pox |
02/19/1998 | WO1997049805A3 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
02/19/1998 | WO1997049423A3 Liposomal influenza vaccine composition and method |
02/19/1998 | WO1997048799A3 Polynucleotides from human fetal brain encoding secreted proteins |
02/19/1998 | WO1997048408A3 Method for the prevention and treatment of mastitis |
02/19/1998 | WO1997046587A3 Ob protein binding protein |
02/19/1998 | WO1997046254A3 Reagents and methods for inhibiting cytokine release by blood cells |
02/19/1998 | WO1997044451A3 Vasoactive amine binding molecules |
02/19/1998 | WO1997044356A3 Ret ligand (retl) for stimulating neural and renal growth |
02/19/1998 | WO1997041155A3 Compositions and methods for isolating lung surfactant hydrophobic proteins sp-b and sp-c |
02/19/1998 | WO1997039120A3 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression |
02/19/1998 | WO1997038085A3 Genes amplified in cancer cells |
02/19/1998 | WO1997031016A3 New inhibitors of sh2-mediated processes |
02/19/1998 | DE19632773A1 Neue Thrombininhibitoren New thrombin inhibitors |
02/19/1998 | DE19632772A1 Neue Benzamidine New benzamidines |
02/19/1998 | DE19632564A1 Bergofungin peptide |
02/19/1998 | CA2263789A1 Acylated peptide cytolytic peptide inhibitors |
02/19/1998 | CA2263730A1 Delivery of tolerogenic antigens via edible plants or plant-derived products |
02/19/1998 | CA2263728A1 Dendritic cells produced in serum-free culture |
02/19/1998 | CA2263722A1 Cytokine-free culture of dendritic cells |
02/19/1998 | CA2263706A1 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
02/19/1998 | CA2263416A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin |
02/19/1998 | CA2263344A1 Dipeptide benzamidine as a kininogenase inhibitor |
02/19/1998 | CA2263338A1 Therapeutic compositions for treatment of cancer |
02/19/1998 | CA2263316A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
02/19/1998 | CA2263220A1 Thrombin inhibitors |
02/19/1998 | CA2263219A1 Methods and means for modifying complement activation |
02/19/1998 | CA2263195A1 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
02/19/1998 | CA2263172A1 Two human nsp-like proteins |
02/19/1998 | CA2263169A1 Human dbi/acbp-like protein |
02/19/1998 | CA2263165A1 Human induced tumor protein |
02/19/1998 | CA2263164A1 Enhancement of antimicrobial peptide activity by metal ions |
02/19/1998 | CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
02/19/1998 | CA2262748A1 Defining epitopes of the outer membrane protein copb of moraxella catarrhalis |
02/19/1998 | CA2262507A1 Expression vectors, cells, and methods for preparing thrombopoietin polypeptides |
02/19/1998 | CA2262432A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
02/19/1998 | CA2262427A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
02/19/1998 | CA2261572A1 Lysyl oxidase synthetic polynucleotides |
02/19/1998 | CA2261130A1 Methods to treat cerebral ischemic injury and other neuronal diseases |
02/18/1998 | EP0824149A2 Glutamine: fructose-6-phosphate amidotransferase (GFAT), its production and use |
02/18/1998 | EP0823942A1 Efflux pump inhibitors |
02/18/1998 | EP0823913A1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof |
02/18/1998 | EP0823895A1 Fatty acid esters as bioactive compounds |
02/18/1998 | EP0823889A1 1,3-propane diol derivatives as bioactive compounds |
02/18/1998 | EP0823848A1 Tissue adhesive using synthetic cross-linking |
02/18/1998 | EP0675900B1 Antibiotics ge 37468 a, b and c |
02/18/1998 | CN1173897A Eukaryotic initiation factor SA (eif-5A) mutants |
02/18/1998 | CN1173896A Novel DNAS, novel polypeptides and novel antibodies |
02/18/1998 | CN1173877A Novel membrane proteins of helicobacter pylori |
02/18/1998 | CN1173876A Novel membrane proteine P76 of helicobacter pylori |
02/18/1998 | CN1173875A Process for preparing certain AZA Cyclohexapeptides |
02/18/1998 | CN1173874A Novel farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compsns containing same |
02/18/1998 | CN1173873A Novel farnesyl transferase inhibitors, proparation thereof, and pharmaceutical compositions containing same |
02/18/1998 | CN1173872A Thrombin inhibitors |
02/18/1998 | CN1173817A Method, compsns and kits for increasing the oral bioavilability of pharmaceuticalagents |
02/18/1998 | CN1173815A Liposome formulations of 5'beta' steroids |
02/18/1998 | CN1173500A PEG-interferon conjugates |
02/18/1998 | CN1037454C Snail bioenzyme |
02/17/1998 | US5719296 Therapy, prevention of autoimmune diseases; prevents peptide binding to major histocompatbility complex proteins |
02/17/1998 | US5719287 Intermediates for inhibitors of HIV protease and method of preparation thereof |
02/17/1998 | US5719268 Endothelial cell adhesion molecules |
02/17/1998 | US5719267 Clostridial toxin disease therapy |
02/17/1998 | US5719266 Genetic engineered polypeptide |
02/17/1998 | US5719265 Antitumor agents with improved water solubility and reduced toxicity |
02/17/1998 | US5719192 Orally administering to treat pneumocystis carinii pneumonia |
02/17/1998 | US5719160 Method for modifying and regulating lipid metabolism |
02/17/1998 | US5719128 Factor IIa inhibitors |
02/17/1998 | US5719127 Modified complement system regulators |
02/17/1998 | US5719126 Melanogenic inhibitor, and methods of producing and using the same |
02/17/1998 | US5719125 Human chondromodulin-I protein |